4.7
慢性支气管炎是慢性阻塞性肺疾病(COPD)的关键表型,其特征是气道为中心的炎症和黏液过度分泌。该病由长期暴露于有害颗粒或气体(最常见的是香烟烟雾)引起,这些刺激物会触发持续的炎症反应。
炎症最初累及大气道,随后波及较小气道,伴有免疫细胞浸润,包括中性粒细胞、巨噬细胞和淋巴细胞。气道上皮发…
慢性支气管炎是慢性阻塞性肺疾病(COPD)的主要表型,由长期暴露于香烟烟雾等空气刺激物引起。
这些刺激物会引发持续性炎症,炎症始于较大的支气管,并延伸至较小的气道。
中性粒细胞、巨噬细胞和淋巴细胞浸润支气管壁,导致上皮损伤。
炎症还会引起鳞状上皮化生,即以鳞状细胞替代纤毛上皮,从而损害黏液纤毛清除功能。
与此同时,杯状细胞和黏膜下腺体发生增生和肥大,产生大量黏稠的黏液,阻塞气道并促进感染。
持续的炎症和黏液栓塞导致气道重塑,包括平滑肌肥大和纤维化,使气道变窄,尤其在呼气时更为明显。
气道阻塞导致通气-血流比例失调,从而引起低氧血症。进行性气体陷闭引起肺过度充气,使膈肌变平,降低通气效率,并增加呼吸做功。
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.